StockVS

NASDAQ · USD

Biofrontera Inc. (BFRIW) Stock Analysis

Biofrontera Inc. (BFRIW) is a stock listed on NASDAQ and quoted in US Dollar.

BFRIW

$0.02

−$0.00 (−9.91%)

Sep 4, 2026 · Market close

This is a derivative instrument — a warrant on Biofrontera Inc. (BFRI) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View BFRI →

Price History

Hover for the daily close. The dotted line marks the period open.

BFRIW Key Statistics

As of Sep 4, 2026
Trading
Open
$0.10
Previous Close
$0.02
Day's Range
0.02–0.02
52-Week Range
0.02–0.02
Volume
25.40K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.84

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Recent News

News provided by third-party sources. Not financial advice.

About Biofrontera Inc.

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Visit website →